Macrae Sandy has filed 24 insider transactions across 1 company since January 2024.
Most recent transaction: a grant/award of 2500000 shares of SANGAMO THERAPEUTICS, INC ($SGMO) on April 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | A | Stock Option (Right to Buy) | 2500000 | $0.00 | 2,500,000.0000 | 336,494,489 | 9999.99% | 0.74% |
| Feb. 25, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 33637 | $0.47 | 1,907,656.0000 | 336,494,489 | 1.73% | 0.01% |
| Feb. 24, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 5291 | $0.47 | 1,941,293.0000 | 336,494,489 | 0.27% | 0.00% |
| Jan. 22, 2026 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 102950 | $0.40 | 1,946,584.0000 | 336,494,489 | 5.02% | 0.03% |
| Nov. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7488 | $0.42 | 2,049,534.0000 | 336,494,489 | 0.36% | 0.00% |
| Oct. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 126950 | $0.66 | 2,057,022.0000 | 224,710,019 | 5.81% | 0.06% |
| Aug. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7488 | $0.59 | 2,183,972.0000 | 224,710,019 | 0.34% | 0.00% |
| July 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 126950 | $0.48 | 2,191,460.0000 | 224,710,019 | 5.48% | 0.06% |
| May 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7488 | $0.47 | 2,318,410.0000 | 224,710,019 | 0.32% | 0.00% |
| April 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 126950 | $0.78 | 2,325,898.0000 | 224,710,019 | 5.18% | 0.06% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | A | Stock Option (Right to Buy) | 1750000 | $0.00 | 1,750,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7488 | $1.00 | 2,088,511.0000 | 0 | 0.36% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 10663 | $0.96 | 2,077,848.0000 | 0 | 0.51% | 0.00% |
| Feb. 25, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | A | Common Stock | 375000 | $0.00 | 2,452,848.0000 | 0 | 18.05% | 0.00% |
| Jan. 22, 2025 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 412584 | $1.15 | 2,095,999.0000 | 0 | 16.45% | 0.00% |
| Nov. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7473 | $1.88 | 2,519,225.0000 | 0 | 0.30% | 0.00% |
| Nov. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 10642 | $1.94 | 2,508,583.0000 | 0 | 0.42% | 0.00% |
| Aug. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7492 | $0.86 | 2,526,698.0000 | 0 | 0.30% | 0.00% |
| Aug. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 5261 | $0.86 | 2,534,190.0000 | 0 | 0.21% | 0.00% |
| May 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 7492 | $0.60 | 2,539,451.0000 | 0 | 0.29% | 0.00% |
| May 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 5261 | $0.60 | 2,546,943.0000 | 0 | 0.21% | 0.00% |
| Feb. 25, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 24157 | $1.13 | 2,552,204.0000 | 0 | 0.94% | 0.00% |
| Feb. 24, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | F | Common Stock | 16115 | $1.13 | 2,576,361.0000 | 0 | 0.62% | 0.00% |
| Jan. 22, 2024 | SANGAMO THERAPEUTICS, INC | $SGMO | Macrae Sandy | PRESIDENT, CEO AND DIRECTOR | A | Common Stock | 2000000 | $0.00 | 2,592,476.0000 | 0 | 337.57% | 0.00% |